edit-301
Editas Medicine
['ruby']
#happeningnow at #eha2023: editas presenting clinical data from the ruby trial of edit-301 for the treatment of severe sickle cell disease. #sicklecelldisease #geneediting #biotechnology
At Editas Medicine, we are pioneering the possible, harnessing the potential of CRISPR gene editing to develop medicines for people living with serious diseases